Tuesday, 28 August 2012

Methicillin-Resistant Staphylococcus Aureus-Community Acquired Pneumonia-The European Commission

AstraZeneca wins EU approval for new antibiotic

(Reuters) - AstraZeneca said on Tuesday it had won European approval for Zinfor, a new intravenous antibiotic to treat complicated skin and soft tissue infections or community acquired pneumonia. The green light from the European Commission makes Zinfor the only approved cephalosporin monotherapy in Europe against methicillin-resistant Staphylococcus aureus (MRSA). (Reporting by Ben Hirschler) read more..

No comments:

Post a comment